Co-Diagnostics (NASDAQ:CODX) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.
Earnings and Valuation
This table compares Co-Diagnostics and OrthoPediatrics' top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
|---|
| Co-Diagnostics | $220,000.00 | 1,185.73 | $-6,200,000.00 | ($0.36) | -25.28 |
| OrthoPediatrics | $72.55 million | 13.43 | $-13,730,000.00 | ($0.87) | -56.95 |
Co-Diagnostics has higher earnings, but lower revenue than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Co-Diagnostics, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of current ratings and target prices for Co-Diagnostics and OrthoPediatrics, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
|---|
| Co-Diagnostics | 0 | 1 | 1 | 0 | 2.50 |
| OrthoPediatrics | 0 | 0 | 3 | 0 | 3.00 |
Co-Diagnostics currently has a consensus price target of $18.00, suggesting a potential upside of 97.80%. OrthoPediatrics has a consensus price target of $55.80, suggesting a potential upside of 12.61%. Given Co-Diagnostics' higher possible upside, equities analysts plainly believe Co-Diagnostics is more favorable than OrthoPediatrics.
Profitability
This table compares Co-Diagnostics and OrthoPediatrics' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
|---|
| Co-Diagnostics | 53.81% | 93.48% | 88.06% |
| OrthoPediatrics | -34.26% | -11.57% | -8.79% |
Institutional and Insider Ownership
27.1% of Co-Diagnostics shares are held by institutional investors. Comparatively, 71.7% of OrthoPediatrics shares are held by institutional investors. 2.3% of Co-Diagnostics shares are held by company insiders. Comparatively, 33.6% of OrthoPediatrics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Volatility and Risk
Co-Diagnostics has a beta of -3.3, suggesting that its share price is 430% less volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500.
Summary
Co-Diagnostics beats OrthoPediatrics on 8 of the 14 factors compared between the two stocks.
